{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:41:50Z","timestamp":1792856510034,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00406114"],"award-info":[{"award-number":["RS-2024-00406114"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-00517908"],"award-info":[{"award-number":["RS-2025-00517908"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114733","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T23:35:07Z","timestamp":1771198507000},"page":"114733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Protein corona-guided delivery of dextran-PLGA NPs for enhanced dendritic cell uptake, maturation and improved cancer immunotherapy"],"prefix":"10.1016","volume":"392","author":[{"given":"An Thi Thanh","family":"Vu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu-Huyen","family":"Le Thi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khang-Yen","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoa Thi Kim","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seho","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Kyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Sun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeg Kyu","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Heon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jconrel.2026.114733_bb0005","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.3390\/ma16155354","article-title":"Nanoparticles in cancer diagnosis and treatment","volume":"16","author":"Baranwal","year":"2023","journal-title":"Materials (Basel)"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114733_bb0010","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.apsb.2022.03.017","article-title":"An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12951-023-02106-8","article-title":"Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy","volume":"21","author":"Shi","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114733_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1211262","article-title":"Research progress of nanovaccine in anti-tumor immunotherapy","volume":"13","author":"Yao","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114733_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011144","article-title":"CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells","volume":"5","author":"Yewdall","year":"2010","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.jconrel.2026.114733_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163842","article-title":"Nanovaccines for cancer prevention and immunotherapy: an update review","volume":"14","author":"Fang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.114733_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115992","article-title":"Nanovaccines: an effective therapeutic approach for cancer therapy","volume":"170","author":"Gurunathan","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.114733_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109887","article-title":"Nanovaccines for cancer immunotherapy: focusing on complex formation between adjuvant and antigen","volume":"117","author":"Hashemi Goradel","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114733_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13770-023-00527-y","article-title":"Enhancement of immune responses elicited by nanovaccines through a cross-presentation pathway","volume":"20","author":"Kim","year":"2023","journal-title":"Tissue Eng. Regener. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40005-023-00646-7","article-title":"Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy","volume":"54","author":"Shim","year":"2024","journal-title":"J. Pharm. Investig."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114733_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615240","article-title":"Cancer vaccines: adjuvant potency, importance of age, lifestyle, and treatments","volume":"11","author":"Cuzzubbo","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114733_bb0075","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/med.22016","article-title":"cGAS-STING pathway agonists are promising vaccine adjuvants","volume":"44","author":"Tian","year":"2024","journal-title":"Med. Res. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114733_bb0080","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.3390\/cancers13112695","article-title":"STING agonists as cancer therapeutics","volume":"13","author":"Amouzegar","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40364-023-00551-z","article-title":"Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy","volume":"12","author":"Chen","year":"2024","journal-title":"Biomark. Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114733_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06638-1","article-title":"STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells","volume":"15","author":"Wang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.24272\/j.issn.2095-8137.2022.464","article-title":"Current understanding of the cGAS-STING signaling pathway: structure, regulatory mechanisms, and related diseases","volume":"44","author":"Pan","year":"2023","journal-title":"Zool. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2026.114733_bb0100","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1016\/j.celrep.2017.11.061","article-title":"Trafficking-mediated STING degradation requires sorting to acidified endolysosomes and can be targeted to enhance anti-tumor response","volume":"21","author":"Gonugunta","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114733_bb0105","article-title":"Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: a comprehensive review of strategies and future perspectives","volume":"23","author":"Huang","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.jconrel.2026.114733_bb0110","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/med.21649","article-title":"Agonists and inhibitors of the STING pathway: potential agents for immunotherapy","volume":"40","author":"Wu","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0115","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114733_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202100133","article-title":"Nanoparticle-mediated STING agonist delivery for enhanced cancer immunotherapy","volume":"21","author":"Zhou","year":"2021","journal-title":"Macromol. Biosci."},{"issue":"556","key":"10.1016\/j.jconrel.2026.114733_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6606","article-title":"Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"35","key":"10.1016\/j.jconrel.2026.114733_bb0130","doi-asserted-by":"crossref","first-page":"24219","DOI":"10.1021\/acsnano.4c05657","article-title":"Stimulator of interferon genes-activated biomimetic dendritic cell nanovaccine as a chemotherapeutic booster to enhance systemic fibrosarcoma treatment","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2026.114733_bb0135","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1021\/cbe.4c00105","article-title":"Protein Corona of nanoparticles: isolation and analysis","volume":"1","author":"Sun","year":"2024","journal-title":"Chem. Bio. Eng."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-3155-11-26","article-title":"Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle","volume":"11","author":"Saptarshi","year":"2013","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114733_bb0145","series-title":"Protein Coronas Derived From Cerebrospinal Fluid Enhance the Interactions Between Nanoparticles and Brain Cells","author":"Morshed","year":"2024"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0150","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/s41467-018-04873-7","article-title":"Revealing the immune perturbation of black phosphorus nanomaterials to macrophages by understanding the protein corona","volume":"9","author":"Mo","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114733_bb0155","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1021\/acsami.9b15910","article-title":"Corona of thorns: the surface chemistry-mediated protein Corona perturbs the recognition and immune response of macrophages","volume":"12","author":"Cai","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0160","article-title":"Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114733_bb0165","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s40005-023-00633-y","article-title":"Pattern recognition receptors and their nano-adjuvants for cancer immunotherapy","volume":"53","author":"Li","year":"2023","journal-title":"J. Pharm. Investig."},{"issue":"40","key":"10.1016\/j.jconrel.2026.114733_bb0170","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1039\/D2TB01296K","article-title":"The amount of dextran in PLGA nanocarriers modulates protein corona and promotes cell membrane damage","volume":"10","author":"Antonio","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biomaterials.2005.04.041","article-title":"Influence of polysaccharide coating on the interactions of nanoparticles with biological systems","volume":"27","author":"Lemarchand","year":"2006","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114733_bb0180","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jaci.2017.08.049","article-title":"Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses","volume":"142","author":"Shen","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114733_bb0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ijpharm.2017.04.048","article-title":"Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona","volume":"532","author":"Coty","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2026.114733_bb0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1039\/C9NA00537D","article-title":"Isolation methods for particle protein corona complexes from protein-rich matrices","volume":"2","author":"B\u00f6hmert","year":"2020","journal-title":"Nanoscale Adv."},{"issue":"9","key":"10.1016\/j.jconrel.2026.114733_bb0195","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/nprot.2014.139","article-title":"Quantitative profiling of the protein coronas that form around nanoparticles","volume":"9","author":"Docter","year":"2014","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.jconrel.2026.114733_bb0200","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm.4200","article-title":"Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses","volume":"22","author":"Moynihan","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.114733_bb0205","first-page":"232","article-title":"Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy","volume":"16","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2026.114733_bb0210","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40005-023-00644-9","article-title":"Development of nano-immunotherapy for cancer treatment: achievements and scopes","volume":"53","author":"Raj","year":"2023","journal-title":"J. Pharm. Investig."},{"issue":"8","key":"10.1016\/j.jconrel.2026.114733_bb0215","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.1021\/acsnano.5b03300","article-title":"In vivo biomolecule Corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles","volume":"9","author":"Hadjidemetriou","year":"2015","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.jconrel.2026.114733_bb0220","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1021\/acsnano.9b03824","article-title":"Corona composition can affect the mechanisms cells use to internalize nanoparticles","volume":"13","author":"Francia","year":"2019","journal-title":"ACS Nano"},{"issue":"24","key":"10.1016\/j.jconrel.2026.114733_bb0225","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1016\/j.biomaterials.2014.04.067","article-title":"The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets","volume":"35","author":"De Paoli","year":"2014","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114733_bb0230","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3390\/ijms22062869","article-title":"Complement-opsonized nano-carriers are bound by dendritic cells (DC) via complement receptor (CR)3, and by B cell subpopulations via CR-1\/2, and affect the activation of DC and B-1 cells","volume":"22","author":"Bednarczyk","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114733_bb0235","first-page":"151","article-title":"In vitro and in vivo differences in murine third complement component (C3) opsonization and macrophage\/leukocyte responses to antibody-functionalized iron oxide nanoworms","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114733_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217410","article-title":"STING in cancer immunoediting: modeling tumor-immune dynamics throughout cancer development","volume":"612","author":"Zhang","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"STING: a master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2026.114733_bb0250","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.jconrel.2026.114733_bb0255","article-title":"The combination of morphology and surface chemistry defines the immunological identity of nanocarriers in human blood","volume":"4","author":"Vincent","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jconrel.2026.114733_bb0260","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/IJN.S269986","article-title":"Peptide-based nanovaccines in the treatment of cervical cancer: a review of recent advances","volume":"17","author":"Zhang","year":"2022","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"cGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114733_bb0270","doi-asserted-by":"crossref","unstructured":"T.M. Clay, A. Hobeika, T. Osada, D. Serra, D. Niedzwiecki, H.K. Lyerly, M.A. Morse, Depletion of human regulatory T cells (Treg) and antigen-specific immune responses to cancer vaccines, J. Clin. Oncol. 26(15_suppl) 3010\u20133010. doi:https:\/\/doi.org\/10.1200\/jco.2008.26.15_suppl.3010.","DOI":"10.1200\/jco.2008.26.15_suppl.3010"},{"issue":"6","key":"10.1016\/j.jconrel.2026.114733_bb0275","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0280","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.jconrel.2026.114733_bb0285","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/iep.12192","article-title":"Novel murine tumour models depend on strain and route of inoculation","volume":"97","author":"Fu","year":"2016","journal-title":"Int. J. Exp. Pathol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.114733_bb0290","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1409929","article-title":"Enhanced protection of C57 BL\/6 vs Balb\/c mice to melanoma liver metastasis is mediated by NK cells","volume":"7","author":"Foerster","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.etap.2012.10.002","article-title":"Inhibition of tumor growth in vitro and in vivo by fucoxanthin against melanoma B16F10 cells","volume":"35","author":"Kim","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.114733_bb0300","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/intimm\/dxh073","article-title":"Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse","volume":"16","author":"Takeshita","year":"2004","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.114733_bb0305","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114733_bb0310","doi-asserted-by":"crossref","first-page":"S1446","DOI":"10.1016\/j.annonc.2020.10.559","article-title":"71P a phase II study of ADU-S100 in combination with pembrolizumab in adult patients with PD-L1+ recurrent or metastatic HNSCC: preliminary safety, efficacy and PK\/PD results","volume":"31","author":"Zandberg","year":"2020","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.114733_bb0315","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-022-01363-8","article-title":"Combination of oral STING agonist MSA-2 and anti-TGF-\u03b2\/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors","volume":"15","author":"Yi","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6506","key":"10.1016\/j.jconrel.2026.114733_bb0320","doi-asserted-by":"crossref","first-page":"eaba6098","DOI":"10.1126\/science.aba6098","article-title":"An orally available non-nucleotide STING agonist with antitumor activity","volume":"369","author":"Pan","year":"2020","journal-title":"Science"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:38:17Z","timestamp":1787128697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":64,"alternative-id":["S0168365926001355"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114733","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein corona-guided delivery of dextran-PLGA NPs for enhanced dendritic cell uptake, maturation and improved cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114733"}}